An extension study of the patients enrolled in acute graft versus host disease (GVHD) prophylaxis study (Protocol No. FJ-506E-BT01) to assess safety and efficacy of GVHD prophylaxis of a tacrolimus new oral formulation (MR4).
Get More Information
Would you like more information about clinical trial sites that are recruiting participants for A study to assess the safety and efficacy of a tacrolimus new oral formulation (MR4) in BMT patients-Extension-? Contact us by filling our your information to the right and we’ll respond to you.